Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conjugated estrogen as a post-ovulatory interceptive

M Notelovitz, D S Bard

    Contraception
    |May 1, 1978
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estradiol absorption from vaginal tablets in postmenopausal women.

    Obstetrics and gynecology·2002
    Same author

    Effects of estrogen/androgen therapy on bone mineral density parameters.

    The Journal of reproductive medicine·2001
    Same author

    Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol.

    Menopause (New York, N.Y.)·2000
    Same author

    The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara).

    Menopause (New York, N.Y.)·2000
    Same author

    Urogenital atrophy and low-dose vaginal estrogen therapy.

    Menopause (New York, N.Y.)·2000
    Same author

    Initial 17beta-estradiol dose for treating vasomotor symptoms.

    Obstetrics and gynecology·2000
    Same journal

    Crisis Pregnancy Center Names in the United States, 2024.

    Contraception·2026
    Same journal

    Findings from the Choices about Abortion CaRE Options (CARE) Study: A Discrete-Choice Experiment.

    Contraception·2026
    Same journal

    Comparative effectiveness of 200mcg versus 400mcg misoprostol dosing for medication abortion from 24-27 weeks' gestation.

    Contraception·2026
    Same journal

    Reasons patients decide to replace or extend their long-acting reversible contraceptive before the full duration of pregnancy prevention: a qualitative study.

    Contraception·2026
    Same journal

    Awareness of abortion medications by mail options among abortion patients at 6 clinics: Findings from a pilot study.

    Contraception·2026
    Same journal

    A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injection.

    Contraception·2026
    See all related articles